Kidney cancer, Renal cell cancer, Secondary cancers
Results
Phase 3
This trial compared pazopanib with sunitinib as treatment for the most common type of kidney cancer called renal cell cancer. It was for people who had not yet had any treatment for kidney cancer that had spread (advanced kidney cancer).
Recruitment start: 17 May 2010
Recruitment end: 26 April 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Hawkins
GlaxoSmithKline (GSK)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 19 May 2013
CRUK internal database number: 6693
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
